Equity AB Frankenius insider trades
Open-market stock purchases and sales by Equity AB Frankenius, 10% Owner at TriSalus Life Sciences, Inc, from SEC Form 4 filings since Dec 17, 2024.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -19%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- TLSI TriSalus Life Sciences, Inc: 1 buy, last Jul 31, 2025
Get free alerts when Equity AB Frankenius files a new trade →